FDA’s economist in chief

FDA’s economist in chief
Foes and friends of Mark McClellan agree on at least one point: The Food and Drug Administration commissioner is very popular with the drug industry he regulates. This article profiles opinions of Mark McClennan’s performance as FDA commissioner.


Leave a Reply

Your email address will not be published. Required fields are marked *